Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Frontiers in Medicine|December 29, 2025
Association between CRP-TyG index and hepatic synthetic function in post-myocardial infarction ICU patientsJiao Bao, Jiejun Hu, Xiangyin LvFrontiers in Physiology|May 8, 2026
Comparative associative and discriminative value of inflammatory, coagulation, hypoxia-perfusion, and electrolyte-metabolic indices for early respiratory physiological decompensation in acute pancreatitisXiangyin Lv, Jiejun Hu, Jiao BaoSensors (Basel, Switzerland)|January 20, 2021
Hybrid Blockchain for IoT-Energy Analysis and Reward PlanJiejun Hu, Martin J Reed, Mays Al-Naday, et al.Frontiers in Oncology|May 3, 2021
Suppression of Heterogeneous Nuclear Ribonucleoprotein C Inhibit Hepatocellular Carcinoma Proliferation, Migration, and Invasion <i>via</i> Ras/MAPK Signaling PathwayJiejun Hu, Dong Cai, Zhibo Zhao, et al.BMC Gastroenterology|August 20, 2020
Left-sided portal hypertension caused by peripancreatic lymph node tuberculosis misdiagnosed as pancreatic cancer: a case report and literature reviewDajun Yu, Xiaolan Li, Jianping Gong, et al.Frontiers in Oncology|October 14, 2021
Identification of a Prognostic Model Based on 2-Gene Signature and Analysis of Corresponding Tumor Microenvironment in Alcohol-Related Hepatocellular CarcinomaYong Guo, Jiejun Hu, Zhibo Zhao, et al.Frontiers in Surgery|April 8, 2022
Identification of the Tumor Immune Microenvironment and Therapeutic Biomarkers by a Novel Molecular Subtype Based on Aging-Related Genes in Hepatocellular CarcinomaDong Cai, Zhibo Zhao, Jiejun Hu, et al.Frontiers in Oncology|May 31, 2021
Identification of Mutator-Derived Alternative Splicing Signatures of Genomic Instability for Improving the Clinical Outcome of CholangiocarcinomaZijing Lin, Jianping Gong, Guochao Zhong, et al.Bioscience Trends|April 16, 2025
SNRPA promotes hepatocellular carcinoma proliferation and lenvatinib resistance via B7-H6-STAT3/AKT axis by facilitating B7-H6 pre-mRNA maturationJiejun Hu, Junhua Gong, Xia Shu, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 3, 2025
Targeting FDFT1 Reduces Cholesterol and Bile Acid Production and Delays Hepatocellular Carcinoma Progression Through the HNF4A/ALDOB/AKT1 AxisDong Cai, Guo-Chao Zhong, Xin Dai, et al.Pageof 2